Physician​/Oncology​/Maryland​/Locum tenens​/Hematology & Oncology Physician

Position: Physician / Oncology / Maryland / Locum tenens / Hematology & Oncology Physician Job
JOB OVERVIEW

Job Title:

Physician Hematology/Oncology Job Type: Locum Tenens

Location:

Towson, MD Service Setting:
Inpatient & Outpatient Hospital Coverage Type:
Clinical + Call Coverage Period:
December 5, 2025 Ongoing Clinical Shift

Schedule:

Mon Thurs, 8:30a4:00p On-Call Shift

Schedule:

One weekday night call + every 4th weekend (Fri 8aMon 8a) Call Type:
In-House;
Telephone Call Ratio: 1:4 weekends Call Response Time: 30 minutes Callback Rate:
Approx. 5 admissions per night on call COVERAGE DATES Starting December 5, 2025 Ongoing assignment, long-term preferred PATIENT INFORMATION Patient Demographics:
Adult only (100%) Patient Volume/Census: 1215 patients per day (mix of new and follow-up visits) Admissions:
Yes inpatient oncology consults and follow-ups Rounding:
Included Phone Consults:
Yes Case Mix:
General Hematology and Oncology FACILITY INFORMATION No. of Beds in Department: 221 Trauma Level: N/A EMR System: EPIC Beacon Specialty Backup Available: APP team for inpatient coverage Support Staff Available:
Inpatient APP during normal hours Reason for Coverage:
Turnover vacancy (replacing departing provider) PRIVILEGES & COMPLIANCE Hospital Privileges

Required:

Yes Temporary Privileges Available:
Yes Credentialing Timeline: 60 days COMPENSATION & BENEFITS Travel, Lodging, and Malpractice Insurance:
Covered Workstation:
Provided on-site REQUIRED PROCEDURES General oncology and hematology consultations Chemotherapy management and inpatient follow-ups Coordination of care with oncology APP team JOB REQUIREMENTS Licenses:
Active MD license or IMLC accepted Board:
Board Certified in Hematology & Oncology DEA:
Required

Certifications:

BLS

Experience:

Minimum 3 years post-training Other

Qualifications:

EPIC experience required DUTIES & RESPONSIBILITIES Provide outpatient clinic coverage 4 days/week (Mon Thurs) Manage inpatient consults and follow-up oncolog